Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Müllerian hormone levels

Chang, Hye Jin; Han, Sang Hoon; Lee, Jung Ryeol; Jee, Byung Chul; Lee, Byoung Ick; Suh, Chang Suk; Kim, Seok Hyun

doi:10.1016/j.fertnstert.2009.02.022

Cited by 253 publications

(234 citation statements)

References 39 publications

Supporting

Mentioning

199

Contrasting

Unclassified

Order By: Relevance

“…In this situation, it is not surprising that researchers began to adopt serum AMH levels. Chang and Iwase were the first to report the decline of serum AMH levels after excision of endometrioma(s), especially in bilateral cases [91,92]. Afterwards, numerous other reports confirmed that AMH levels decreased after removal of endometriomas [93][94][95][96], and steeper reductions were observed after bilateral procedures [97,98].…”

Section: Decrease Of Ovarian Reserve In Relation To Gynecologic Diseamentioning

confidence: 97%

Anti‐Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?

Iwase

Nakamura

Osuka

et al. 2015

Reprod Medicine & Biology

View full text Add to dashboard Cite

Ovarian reserve reflects the quality and quantity of available oocytes. This reserve has become indispensable for the better understanding of reproductive potential. Measurement of the serum anti-Müllerian hormone (AMH) level allows quantitative evaluation of ovarian reserve. It has been applied to a wide range of clinical conditions, and it is well established that the measurement of serum AMH levels is more useful than qualitative evaluation based on the menstrual cycle. AMH levels are monitored during infertility treatments; in patients undergoing medically assisted reproductive technology; and in the diagnosis of ovarian failure, polycystic ovarian syndrome, and granulosa cell tumor. It is also useful in the evaluation of iatrogenic ovarian damage. Population-based studies have indicated a potential role for serum AMH in the planning of reproductive health management. While AMH is currently the best measure of ovarian reserve, its predictive value for future live births remains controversial. Furthermore, there is a serious practical issue in the interpretation of test results, as currently available assay kits use different assay ranges and coefficients of variation due to the absence of an international reference standard. The pros and cons of the serum AMH level as a definitive measure of ovarian reserve merits further review in order to guide future research.

show abstract

Section: Decrease Of Ovarian Reserve In Relation To Gynecologic Diseamentioning

confidence: 97%

Anti‐Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?

Iwase

Nakamura

Osuka

et al. 2015

Reprod Medicine & Biology

View full text Add to dashboard Cite

show abstract

“…Improvement in AMH levels after 3 months ovary injury, was also shown after cystectomy (17) . In summary, ovariopexy procedure that was carried out on the posterior aspect of uterus with non absorbable suture may be a satisfactory fixation method, which also protects anatomic and functional relation between the fallopian tube and ovary.…”

Section: Eventsmentioning

confidence: 71%

“…Serum Anti-Müllerian hormone (AMH) level has been suggested to be a reliable marker of ovarian reserve. It was revealed that there is a decrease of 40%-60% in ovary reserve tests after cystectomy carried out for endometrioma or other cysts of one sided oophorectomy (16,17) . The changes in reserve tests of the ovary in recurrent torsions have not been reported in the current literature (2,7) .…”

Section: Eventsmentioning

confidence: 99%

Surgical approaches to recurring torsions and the effects of the attacks on the ovarian reserve: a case study in light of the literature

Üçkuyu¹,

Turhan²,

Çiftçi³

et al. 2013

J Turk Soc Obstet Gynecol

View full text Add to dashboard Cite

show abstract

“…These include accurate assessment of the impact of gonadotoxic therapy, e.g. chemotherapy and radiotherapy, or of ovarian surgery, on the ovarian reserve [29,30]. AMH falls very rapidly with the onset of chemotherapy [31,32].…”

Section: Assessing and Predicting Gonadal Damagementioning

confidence: 99%

Measuring anti-Müllerian hormone for the assessment of ovarian reserve: When and for whom is it indicated?

Anderson¹,

Nelson²,

Wallace³

2012

Maturitas

127

View full text Add to dashboard Cite

a b s t r a c tOur understanding of female reproductive function has been hampered by our inability to directly assess the number of non-growing primordial follicles present in the ovary, the ovarian reserve. Female reproductive hormones (FSH and LH, the inhibins and steroids) reflect the activity of the larger growing follicles and thus are largely informative of peri-ovulatory ovarian activity. In contrast anti-Müllerian hormone (AMH) is a product of the granulosa cells of small growing follicles, whose number (and therefore circulating AMH concentrations) is reflective of the ovarian reserve. AMH declines with age in adult women, and emerging data suggest a relationship with remaining reproductive lifespan and age at the menopause. Early studies demonstrated that AMH concentrations are stable across the menstrual cycle, adding to its clinical utility. The most established role for AMH measurement is in women about to start IVF treatment, where it is predictive of the ovarian response and is of clear value in identifying women at risk of ovarian hyperstimulation syndrome or whose response will be poor and thus their expectations can be tailored. AMH is detectable in childhood, and although relationships to puberty are not yet available, it appears that AMH rises to a peak in the early 20s. Developing indications include in assessment and individualisation of the risk to fertility from chemotherapy, in the diagnosis of PCOS and as a tumour marker in granulosa cell tumours. The increasingly routine use of AMH by IVF clinics heralds much wider adoption in a range of clinical situations across the reproductive lifespan.

show abstract

Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Müllerian hormone levels

Cited by 253 publications

References 39 publications

Anti‐Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?

Anti‐Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?

Surgical approaches to recurring torsions and the effects of the attacks on the ovarian reserve: a case study in light of the literature

Measuring anti-Müllerian hormone for the assessment of ovarian reserve: When and for whom is it indicated?

Contact Info

Product

Resources

About